chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 17yo male came to the office for a Pfizer Covid-19 booster. He received a Moderna Covid-19 booster instead.) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 060H21A) for COVID-19 vaccination. No Medical History information was reported.On 28-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Dec-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 17yo male came to the office for a Pfizer Covid-19 booster. He received a Moderna Covid-19 booster instead.). On 28-Dec-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 17yo male came to the office for a Pfizer Covid-19 booster. He received a Moderna Covid-19 booster instead.) had resolved.For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.No concomitant medications were reported.No treatment medications were reported. Patient was doing fine.
On day 8 after vaccine was administered, the injection site became red , slightly swollen and itchy like an insect bite. I applied some hydrocortisone prescription cream to the area 3 times that day.  No other symptoms. The next day, my left arm became sore, redness had spread considerably around the injection site. It became swollen, red and warm to the touch. I also had some muscle weakness in that arm. I contacted my boss, who is a physician, sent him some photos and he informed me it could be cellulitis and sent me in a Rx for antibiotics. I started the first dose that evening. By the next day, the redness and warmth had improved, still some slight muscle weakness. The day after that, there was only residual post inflammatory hyperpigmentation and no other symptoms.
itchy; site was swollen and red; site was swollen and red; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received bnt162b2 (Formulation: Solution for injection; Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 11Aug2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Caller is a consumer who received the first dose of the Pfizer Biontech COVID19 vaccine on 11Aug2021 and stated that after 8 days, she was itchy and swollen. Caller wants to know if it is normal to have the side effect after 8 days since the usual is 1-3 days after. Caller wants to know if she still experiences the side effect, if she should get the second dose of the Pfizer Biontech COVID19 vaccine. Caller states she is calling to check about the Pfizer covid 19 vaccine and states she took the 1st dose on 11Aug2021 and in the first 1-2 days she did not feel anything and after the 8th day she started feeling itchy and the site was swollen and red and states she knows this may be part of the side effects of the vaccine but after 8 days is this normal because it continues. Caller declined to complete the full report at this time and states right now her main concern is that she wants to speak with somebody about her question. The outcome of the events unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Patient received a flu shot last year and developed pain down the left arm soon after which has lasted to this day. There was soreness at the site after vaccine was given in 2011, then pain down the arm and it has still not gone away. Patient's physician said there may be some nerve damage. No treatment done.
Cellulitis in left arm; A spontaneous report was received from a consumer who is a female patient of unknown age that received Moderna's COVID-19 vaccine (mRNA-1273) and developed cellulitis in left arm/cellulitis after the first dose.  Medical history or concomitant product use were not reported.  On an unknown date, the patient received her first of the two planned doses of mRNA-1273 (batch number: unknown) intramuscularly for prophylaxis of COVID-19 infection.   On an unknown date, the patient developed cellulitis in left arm. Treatment information was not provided. The event cellulitis in left arm was considered to be medically significant.  No action was taken with mRNA-1273 in response to the event.  The outcome of the event cellulitis was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the 1st dose of the product and the start date of the event, a causal relationship cannot be excluded.
Initial report was received 20 May 2008 from a consumer, who is also the patient. Additional information was also 21 May 2008 from the patient's physician. A male patient had received two doses of DECAVAC, lot number U2293CA on 01 April 2008 instead of one dose Tetanus and one dose of Pneumonia vaccines. He was contacted by his physician the next day on 02 April 2008 who inquired about how he felt and wanted to advise him that he had received two doses of Tetanus instead of a dose of Tetanus vaccine and a dose of Pneumonia vaccine the previous morning. The patient reported that he had no reactions other than feeling a little more tired that day. The patient subsequently reported that his blood sugar readings had increased into the 300's on 02 April 2008 through 04 April 2008. He further noted that his A1C drawn on 12 April 2008 was noted to be consistent with an average reading of 400. According to the patient, the lot number for his Tetanus vaccinations had been 40B173 with an expiration date of 30 August 2010. Lot number verification was provided by the patient's physician who indicated the patient had received two left deltoid doses of TD vaccine, manufacturer by sanofi pasteur, lot number U2293CA with an expiration date of 07 May 2009. The patient also stated he began using LANTUS one year ago. No further information was provided at the time of the report. Follow-up information received on 20 June 2008 from the patient's physician. The patient's medical history included hypertension, diabetes and LANTUS. The patient had no illness at the time of vaccination. In April 2008, the patient's hemoglobin A1C was 11.5. According to the physician, the patient's sugar was generally not controlled. The physician reported that the patient fully recovered in the next two days. The physician did not think that there was any relationship between vaccination and sugar.
My daughter had no symptoms after the vaccine. She went to bed with us cause she wasn't sleepy, right as she fell sleep I went to take a picture and the flash set off a seizure (never has had one before) we called 911 and went to ER. She had no fever and seizure was 1-2 min.
My COVID-19 infection symptoms started on 11/24/2022 at night around 8:00PM. I was exposed to it on 11/20/2022. I wasn't feeling well. I had severe headaches, exhausted, and sinus congestion. I did a COVID-19 test on the same day which was positive. I called my doctor's office in the morning and she prescribed me with 1/2 of PAXLOVID for 5 days since I have only 1 kidney she gave me half dose.
Developed presyncope immediately after receiving vaccine and continued to have episodes x 3 ds. Also developed fever to 101.5 and sinus congestion, headache, myalgia and malaise x 5-6 ds that necessitated bedrest. Developed large local reaction even though injection given IM in the deltoid 12 x 12 cm. Symptoms: Fever (780.6), dizziness and giddiness (780.4), malaise and fatigue NEC(780.79), headache(784.0), swelling/mass/lump, localized superficial(782.2).
five employees in a nursing home have gotten the first dose of the vaccine, and then tested positive for COVID; five employees in a nursing home have gotten the first dose of the vaccine, and then tested positive for COVID; This is a spontaneous report from contactable nurse. This nurse reported similar events for 5 patients. This is the second of five reports. A patient of unspecified age and gender received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiry date not reported) via an unspecified route of administration, on an unspecified date, single dose for COVID-19 immunization. Relevant medical history and concomitant medications were not reported. It was reported that five employees in a nursing home have gotten the first dose of the vaccine, and then tested positive for COVID on an unspecified date. They would like to know if they still get the second dose. Outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: The information currently provided is too limited to make a meaningful medical assessment hence, the events are conservatively assessed as related to the suspect drug BNT162B2 until further information becomes available.,Linked Report(s) : US-PFIZER INC-2021021881 Same reporter/ drug/ event for different patients
24 hours post admin, upper arm noted to be swollen, and tender to touch. By Sunday, 9/18/2016 limited range of motion, itching to upper arm and swelling.
The tool has timed out on me 2x already, so I dont have time to give you great detail like I did the first 2x!  Severe adverse include TMJ (right side) and severe rotator cuff tendon pain (left side) Symptoms include:   Jaw - Cannot open my mouth more than 2 fingers. 10/10 pain. Headache, neck pain, tingling right side of my face and head. Arm - cannot raise my arm higher than shoulder length without severe pain.
After receiving vaccine, patient was sitting in observation. Patient passed out in the chair - did not fall. RN assisted patient to wheelchair. Patient regained consciousness prior to transferring. Laid patient down in EMS room cot. Patient's symptoms quickly resolved. BP: 94/58, P:60, R:16, O2 Sats 98% on room air. Repeat BP: 110/52
Information has been received from a pharmacist concerning a 59 year old female patient. The patient's pertinent medical history included "upper respiratory type stuff". There was no drug reactions/allergies reported. In OCT-2014, the patient was vaccinated with a dose of PNEUMOVAX 23 (lot#, expiration date, dose and route not reported). On 26-FEB-2015 the patient was vaccinated with another 0.5 ml dose of PNEUMOVAX 23 (lot # K020214, expiration date 25-MAR-2016, subcutaneous). Other suspect therapies included a vaccination of ZOSTAVAX that occurred in JAN-2015. Concomitant therapies included SYMBICORT. On 27-FEB-2015 the patient called into the pharmacy stating that she developed a "red and swollen area that was 3 or 4 inches" at the injection site. There was no treatment given for the event and no lab diagnostics studies were performed. At the time of reporting, the patient had not recovered from the event. Additional information has been requested.
Swelling from shoulder to base of triceps, very red, and painful to touch. Circled redness noted measured swollen area 4.5 inches top to bottom 2.25 inches side to side.
Patient blacked out and fell while trying to get seated for the observation time after immunization. She also felt like vomiting. I gave her some water and she recovered after about 10 minutes and left the store
Employee received COVID 19 vaccination at 9:45am on 12/30/20. ~15 min. later she developed a rash down her left arm, then down her Rt. arm. about 4 hours later she decided to go to the emergency room for Hearty Palpitations, Fever, Chest discomfort and feeling of generalized sunburn. Later developed severe headache..
3-4 days after the second and third Anthrax injection. I ended up with strep throat. Each time I was treated with an antibiotic successfully. I ached all over and had a temp of 102-103.6.
My son got the MMR shot on January 26th, 2015. Six days later he started with a fever that got very high, he started with pink eye and said his ears were hurting. My son had never had an ear ache before this. I took him into the doctors and they said he had a double ear infection. They gave him his first antibiotic and eye drops for conjunctivitis. That night his fever got even higher. I called the doctors office and asked if any of this could be related to the shot he had only 6 days before this all started. They said no way. He did get better after a few horrible days of a very high fever. He started with a rash on his face. Then his entire body. I searched online and the only rash I could compare it to was measles photos. It wasn't until the rash appeared that I started doing research online and was shocked to read ear infections and inflamed eyes were symptoms of measles. The first half of Feb., 6 days after the MMR shot, I had a very sick 3 year old. The sickest I've ever seen any of my 3 children.
History Chief Complaint Patient presents with ? Covid-19 Screening      ? Nasal Congestion ? Chills     sweats ? Nausea ? Headache
After receiving flu vaccine she had pain in left arm, gradual weakness and loss of range of motion.  Numbness in fingers left hand.
pt recvd vax 10AUG93 & immed following vax pt was cold & clammy, became ashen, felt faint & fainted; BP 80/60; p/about 15 mins father said pt felt fine & they went home;
Initial report was received from a health care professional on 14 June 2012. This is a cluster of two patients who received DAPTACEL and IPOL and developed cellulitis. The other patient was captured in case number 2012-06188. A four-year-old female patient had received the following vaccinations on 11 June 2012: a dose five intramuscular injection in the left thigh of DAPTACEL, sanofi pasteur Ltd., lot number C3944AA, a dose four intramuscular injection in the right thigh of IPOL, sanofi pasteur SA, lot number H1305, an injection of MMR II, Merck (lot number, route and site not reported) and an injection of VARIVAX, Merck (lot number, route and site not reported). On 13 June 2012, the patient experienced a site reaction on the left thigh of redness and swelling. The doctor diagnosed the patient with cellulitis and prescribed "cefeloxin" 250mg/5ml. Illness at the time of vaccination and past medical history were reported as none. The patient's outcome was unknown. Documents held by sender: None.
Excessive redness in the right eye; This is a spontaneous report from a contactable consumer or other non hcp (Patient).   A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced excessive redness in the right eye on an unspecified date. Event took place after use of product. Outcome of the event was unknown.   Reporter does not wish to be contacted for follow-up.  No Follow-up attempts are needed; information about lot/batch number cannot be obtained.
Arm soreness; Dose number 3 received; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received third (BOOSTER) dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0196) via intramuscular route of administration in the left arm on 22Nov2021 at 09:15 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration on an unknown date and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 22Nov2021 at 14:00, the patient experienced arm soreness. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event arm soreness was resolving at the time of this report.
PT FELT LIGHTHEADED AFTER RECEIVING HIS COVID-19 VACCINE.  HE WARNED THE NURSE HE FELT LIGHT HEADED AND PASSED OUT.  PATIENT LOWERED TO THE GROUND, ONCE PATIENT AWAKE JUICE PROVIDED AND TRANSFERRED TO PRIVACY RECOVERY ROOM.  PATIENT PICKED-UP BY EMS
Patient passed out and fell out of chair after receiving his second dose.  He hit his head when he fell.   We called 911 and he was transported to our local hospital. I spoke with his brother and he was released and doing ok.
chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and PYREXIA (fever) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. B36A214) for COVID-19 vaccination.     The patient's past medical history included Lymphoma (non-Hodgkin's) in October 2020 and COVID-19 in November 2020. Concomitant products included RITUXIMAB (RITUXAN) for an unknown indication.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHILLS (chills) and PYREXIA (fever). At the time of the report, CHILLS (chills) and PYREXIA (fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, SARS-CoV-2 test: positive (Positive) Tested positive.         No treatment medications were reported. Patient did Covid test 2 weeks ago and it was negative.   This case was linked to MOD-2021-333559 (Patient Link).
Headache, Itching at injection site, swelling, redness, induration, pain, warmth all at injection site.
I received my second Pfizer COVID-19 vaccine on 02/18/2021 at 1745. The following day around noon I began to have increased bilateral upper extremity pain and left knee pain. Around 1600 that same day I noticed that I was unable to flex/extend my elbows. despite applying heat and doing ROM exercises I was unable to bend my elbows. This was also the case with my left knee. I experienced constant pain and swelling in said joints. This did eventually resolve with nearly full ROM by Monday 02/22/21.
Started to feel ill in the evening after the dose.  Low grade fever at first.  In the middle of the night ran a fever to 100 on Tyelenol.  Couldn't get out of bed the whole next day. Felt weak, light headed, headache, and no appetite.  The fever broke in 24 hours.  Felt tired the following day also.  Took several days to feel back to baseline.
From Juy 3rd to July 10th I had 3 strokes, very high blood pressure.
Initial information received on 20-Jun-2018 regarding an unsolicited valid non-serious case received from a other health professional (Nurse). Linked cases: 2018SA174785 and 2018SA177378 (same reporter). This case involves a 29 years old female patient who experienced tender to touch, site reaction of redness of the site, pea size knot under injection site and had a site reaction, ADACEL. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medication was not reported. On 14-Jun-2018, the patient received 0.5 ml single dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE lot U5875AA (Expiry date: 14-FEB-2020) via intramuscular route in the left deltoid. On 20-Jun-2018, The patient developed a non-serious tender to touch 6 days following the administration of ADACEL. On 20-Jun-2018, The patient developed a non-serious site reaction of redness of the site (vaccination site erythema) 6 days following the administration of ADACEL. On 20-Jun-2018, The patient developed a non-serious pea size knot under injection site 6 days following the administration of ADACEL. Final diagnosis was pea size knot under injection site, site reaction of redness of the site, tender to touch. Lab tests was not reported. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for site reaction of redness of the site, as Unknown for tender to touch, as Unknown for pea size knot under injection site.
NO PAST HX OF REACTIONS,  AFTER IM ADMINISTERED PATIENTREPORTED TINGLING IN HAND COMPLETELY RESOLVED AFTER 15  MINUTES
Serious Shingles.  Also my wife experienced the same issue but not as debilitating.
12/18/07 Gardasil given 12/18/07. 12/19/07 Patient developed swollen lower lip and sl thickness in posterior throat in AM 12/19/07. Had same reaction to food allergy in past. Loratadine 10mg given and symptoms resolved. 12/20/07 Developed 2 large hives on chest and/on back. Loratadine 10mg given. Itching stopped. Hx of milk allergy. Had half and half in cereal both morning then developed symptoms.
Pain and swelling at injection sight. Chills, headache, muscle aches, all day so far
Within 1 week of H1N1 vaccination, the patient developed tingling and numbness of her right hand which over the next 2 weeks came to involve the left hand and both legs below the knees. She denied weakness at the time. The patient was admitted and was noted to have full strength, diminished sensation in the areas of complaint, and absent lower extremity reflexes. A diagnostic workup was performed, without yielding a clear diagnosis. The patient's numbness/tingling became restricted to the feet below the ankles without treatment and have persisted after discharge. Fatigue and stress worsen the symptoms.
Pt recvd rubella vax 24MAR91 & on 5APR91 pt devel rubella-like sx;
Extremely sore arm for several days.  Fever 101 for three days.  Achy body, headache, extreme fatigue for three days.  Sore armpits bilaterally for four weeks.
Swelling in left upper arm "almost twice the size of normal", redness to area covering top of arm almost down to elbow and wrapping 3/4 of way around arm, complain of itching at site,no fever, no dyspnea. Seen on 12/22 in office, no pain, no limit to movement. Treatment: Benadryl 2 tsp every 6 hours as needed and cold compresses.